Allograft and xenograft rejection in C3H/SCID mice. A new model for the study of non-T cell graft rejection mechanisms

Transplantation
H MarcusY Reisner

Abstract

Comparative cell transfer experiments have revealed that, despite their equal immune deficiency, C3H/SCID mice were markedly inferior compared with C.B-17/SCID mice in their ability to accept allogeneic and xenogeneic grafts. Allogeneic C.B-17/SCID bone marrow cells were engrafted poorly compared with syngeneic C3H/SCID when transplanted into C3H/SCID recipients, whereas cells of both strains were equally well engrafted into C.B-17/SCID mice. C.B-17/SCID mice were much more permissive for outgrowth of human Burkitt lymphoma (Raji), as well as for Epstein-Barr virus lymphoma development after transplantation of human peripheral blood lymphocytes. Human skin grafts were accepted by the C.B-17/SCID mice but were promptly rejected by the C3H/SCID mice. The resistance to human RaJi cells could be adoptively transferred by infusion of C3H/SCID splenocytes into C.B-17/SCID mice. Because the C.B-17/SCID and C3H/SCID mice equally lack both T and B lymphocytes, the latter may provide a relevant model for studies of non-T mechanisms of allograft or xenograft rejection.

References

Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·Y ReisnerN Sharon
Jan 1, 1992·Annual Review of Immunology·Y Y YuM Bennett
Jan 1, 1989·Advances in Immunology·G Trinchieri
Mar 1, 1988·The Journal of Experimental Medicine·G C BosmaM J Bosma
Jun 10, 1986·Journal of Immunological Methods·E BaharavI R Cohen
Nov 27, 1986·The New England Journal of Medicine·S C Vlay
Feb 7, 1981·Lancet·P N TrewbyR S Elkeles
Feb 10, 1983·Nature·G C BosmaM J Bosma
Jan 1, 1994·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·P L PollockM I Luster

❮ Previous
Next ❯

Citations

Jan 19, 2000·Immunology Today·R M Smith, T E Mandel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.